SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Regulatory approval is a major milestone in the drug development process, but it is not the final chapter in the journey.
The drugmaker is getting on the AI train in ways that could move the needle down the road.
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...
From survivorship bias to root causes! Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening ...
When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...
The U.S. Food and Drug Administration (FDA) announced a new process called “Rare Disease Evidence Principles” (RDEP), under which eligible drugs and biologics for ultra-rare diseases caused by known ...
The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results